BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bruni N, Stella B, Giraudo L, Della Pepa C, Gastaldi D, Dosio F. Nanostructured delivery systems with improved leishmanicidal activity: a critical review. Int J Nanomedicine 2017;12:5289-311. [PMID: 28794624 DOI: 10.2147/IJN.S140363] [Cited by in Crossref: 48] [Cited by in F6Publishing: 15] [Article Influence: 9.6] [Reference Citation Analysis]
Number Citing Articles
1 Sui L, Xu G, Hao Y, Wang X, Tang K. Engineering of marizomib loaded polymeric nanoparticles: In vivo safety profile and In vitro proliferation in hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2021;66:102840. [DOI: 10.1016/j.jddst.2021.102840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Want MY, Yadav P, Khan R, Chouhan G, Islamuddin M, Aloyouni SY, Chattopadhyay AP, AlOmar SY, Afrin F. Critical Antileishmanial in vitro Effects of Highly Examined Gold Nanoparticles. Int J Nanomedicine 2021;16:7285-95. [PMID: 34737566 DOI: 10.2147/IJN.S268548] [Reference Citation Analysis]
3 Souto EB, Dias-Ferreira J, Craveiro SA, Severino P, Sanchez-Lopez E, Garcia ML, Silva AM, Souto SB, Mahant S. Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological Systems. Pathogens 2019;8:E119. [PMID: 31374930 DOI: 10.3390/pathogens8030119] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Thapa R, Mondal S, Riikonen J, Rantanen J, Näkki S, Nissinen T, Närvänen A, Lehto VP. Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis. PLoS Negl Trop Dis 2021;15:e0009533. [PMID: 34185780 DOI: 10.1371/journal.pntd.0009533] [Reference Citation Analysis]
5 Rebouças-Silva J, Tadini MC, Devequi-Nunes D, Mansur AL, S Silveira-Mattos P, I de Oliveira C, R Formiga F, Berretta AA, Marquele-Oliveira F, Borges VM. Evaluation of in vitro and in vivo Efficacy of a Novel Amphotericin B-Loaded Nanostructured Lipid Carrier in the Treatment of Leishmania braziliensis Infection. Int J Nanomedicine 2020;15:8659-72. [PMID: 33177824 DOI: 10.2147/IJN.S262642] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ghosh C, Varela‐aramburu S, Eldesouky HE, Salehi Hossainy S, Seleem MN, Aebischer T, Seeberger PH. Non‐Toxic Glycosylated Gold Nanoparticle‐Amphotericin B Conjugates Reduce Biofilms and Intracellular Burden of Fungi and Parasites. Adv Therap 2021;4:2000293. [DOI: 10.1002/adtp.202000293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zaccai M, Yarmolinsky L, Khalfin B, Budovsky A, Gorelick J, Dahan A, Ben-Shabat S. Medicinal Properties of Lilium candidum L. and Its Phytochemicals. Plants (Basel) 2020;9:E959. [PMID: 32751398 DOI: 10.3390/plants9080959] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kumar P, Shivam P, Mandal S, Prasanna P, Kumar S, Prasad SR, Kumar A, Das P, Ali V, Singh SK, Mandal D. Synthesis, characterization, and mechanistic studies of a gold nanoparticle-amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity. Int J Nanomedicine 2019;14:6073-101. [PMID: 31686803 DOI: 10.2147/IJN.S196421] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 5.3] [Reference Citation Analysis]
9 Zadeh Mehrizi T, Mosaffa N, Haji Molla Hoseini‎ M, Shafiee Ardestani M, Khamesipour A, Ramezani A. In Vivo Therapeutic Effects of Four Synthesized Antileishmanial Nanodrugs in the Treatment of Leishmaniasis. Arch Clin Infect Dis 2018;In Press. [DOI: 10.5812/archcid.80314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Amer EI, El-Azzouni MZ, El-Bannan RT, Shalaby TI, El-Achy SN, Gomaa MM. Schistosomiasis mansoni: A new therapeutic target for ubiquinol, a natural inhibitor of neutral magnesium-dependent sphingomyelinase in murine model. Acta Trop 2022;226:106231. [PMID: 34785184 DOI: 10.1016/j.actatropica.2021.106231] [Reference Citation Analysis]
11 Sánchez A, Mejía SP, Orozco J. Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections. Molecules 2020;25:E3760. [PMID: 32824757 DOI: 10.3390/molecules25163760] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
12 Singh OP, Gedda MR, Mudavath SL, Srivastava ON, Sundar S. Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application. Nanomedicine (Lond) 2019;14:1911-27. [PMID: 31313971 DOI: 10.2217/nnm-2018-0448] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
13 Liu Y, Guo Q, Sun H, Guo N, Zhang J. Improved therapeutic efficiency of photothermal treatment and nursing care in prostate cancer by DOX loaded PEG coated Cu@Se nano-hybrid vesicle. Process Biochemistry 2020;92:78-84. [DOI: 10.1016/j.procbio.2020.02.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Arshad R, Sargazi S, Fatima I, Mobashar A, Rahdar A, Ajalli N, Kyzas GZ. Nanotechnology for Therapy of Zoonotic Diseases: A Comprehensive Overview. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202201271] [Reference Citation Analysis]
15 Kannan S, Harel Y, Israel LL, Lellouche E, Varvak A, Tsubery MN, Lellouche JP, Michaeli S. Novel Nanocarrier Platform for Effective Treatment of Visceral Leishmaniasis. Bioconjug Chem 2021;32:2327-41. [PMID: 34664934 DOI: 10.1021/acs.bioconjchem.1c00381] [Reference Citation Analysis]
16 da Silva RB, Machado CR, Rodrigues ARA, Pedrosa AL. Selective human inhibitors of ATR and ATM render Leishmania major promastigotes sensitive to oxidative damage. PLoS One 2018;13:e0205033. [PMID: 30265735 DOI: 10.1371/journal.pone.0205033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Bajwa HUR, Khan MK, Abbas Z, Riaz R, Rehman TU, Abbas RZ, Aleem MT, Abbas A, Almutairi MM, Alshammari FA, Alraey Y, Alouffi A. Nanoparticles: Synthesis and Their Role as Potential Drug Candidates for the Treatment of Parasitic Diseases. Life 2022;12:750. [DOI: 10.3390/life12050750] [Reference Citation Analysis]
18 Franch O, Gutiérrez-Corbo C, Domínguez-Asenjo B, Boesen T, Jensen PB, Nejsum LN, Keller JG, Nielsen SP, Singh PR, Jha RK, Nagaraja V, Balaña-Fouce R, Ho YP, Reguera RM, Knudsen BR. DNA flowerstructure co-localizes with human pathogens in infected macrophages. Nucleic Acids Res 2020;48:6081-91. [PMID: 32402089 DOI: 10.1093/nar/gkaa341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Shah S, Shah SA, Faisal S, Khan A, Ullah R, Ali N, Bilal M. Engineering novel gold nanoparticles using Sageretia thea leaf extract and evaluation of their biological activities. J Nanostruct Chem. [DOI: 10.1007/s40097-021-00407-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Petersen ALOA, Campos TA, Dantas DADS, Rebouças JS, da Silva JC, de Menezes JPB, Formiga FR, de Melo JV, Machado G, Veras PST. Encapsulation of the HSP-90 Chaperone Inhibitor 17-AAG in Stable Liposome Allow Increasing the Therapeutic Index as Assessed, in vitro, on Leishmania (L) amazonensis Amastigotes-Hosted in Mouse CBA Macrophages. Front Cell Infect Microbiol 2018;8:303. [PMID: 30214897 DOI: 10.3389/fcimb.2018.00303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
21 Assolini JP, Carloto ACM, Bortoleti BTDS, Gonçalves MD, Tomiotto Pellissier F, Feuser PE, Cordeiro AP, Hermes de Araújo PH, Sayer C, Miranda Sapla MM, Pavanelli WR. Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease - An update overview. Eur J Pharmacol 2022;923:174934. [PMID: 35367420 DOI: 10.1016/j.ejphar.2022.174934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Etxebeste-Mitxeltorena M, Moreno E, Carvalheiro M, Calvo A, Navarro-Blasco I, González-Peñas E, Álvarez-Galindo JI, Plano D, Irache JM, Almeida AJ, Sanmartín C, Espuelas S. Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis. ACS Infect Dis 2021;7:3197-209. [PMID: 34767359 DOI: 10.1021/acsinfecdis.1c00394] [Reference Citation Analysis]
23 Moreira RRD, Santos AGD, Carvalho FA, Perego CH, Crevelin EJ, Crotti AEM, Cogo J, Cardoso MLC, Nakamura CV. Antileishmanial activity of Melampodium divaricatum and Casearia sylvestris essential oils on Leishmania amazonensis. Rev Inst Med Trop Sao Paulo 2019;61:e33. [PMID: 31269109 DOI: 10.1590/S1678-9946201961033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
24 Zadeh Mehrizi T, Shafiee Ardestani M, Haji Molla Hoseini M, Khamesipour A, Mosaffa N, Ramezani A. Novel Nanosized Chitosan-Betulinic Acid Against Resistant Leishmania Major and First Clinical Observation of such parasite in Kidney. Sci Rep 2018;8:11759. [PMID: 30082741 DOI: 10.1038/s41598-018-30103-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
25 de Souza RM, Maranhão RC, Tavares ER, Filippin-Monteiro FB, Nicodemo AC, Morikawa AT, Kanashiro EHY, Amato VS. Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis. Drug Deliv Transl Res 2020;10:403-12. [PMID: 31701487 DOI: 10.1007/s13346-019-00677-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Freitas CS, Oliveira-da-Silva JA, Lage DP, Costa RR, Mendonça DVC, Martins VT, Reis TAR, Antinarelli LMR, Machado AS, Tavares GSV, Ramos FF, Coelho VTS, Brito RCF, Ludolf F, Chávez-Fumagalli MA, Roatt BM, Ramos GS, Munkert J, Ottoni FM, Campana PRV, Humbert MV, Coimbra ES, Braga FC, Pádua RM, Coelho EAF. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitol Res 2021;120:321-35. [PMID: 33191446 DOI: 10.1007/s00436-020-06971-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]